Skip to main content
. 2012 Jun 25;11:15. doi: 10.1186/1744-859X-11-15

Figure 1.

Figure 1

Summary of study schematic from screening through study completion. Visits 6, 7, and 8 were conducted at 4-week intervals. Adverse events were collected from Weeks 1 to 25. Sleep variables were obtained at Week −1 (baseline) and Weeks 1 to 4. SF-36 was assessed at Weeks −1, 4, 12 and 24.